<code id='590EC74086'></code><style id='590EC74086'></style>
    • <acronym id='590EC74086'></acronym>
      <center id='590EC74086'><center id='590EC74086'><tfoot id='590EC74086'></tfoot></center><abbr id='590EC74086'><dir id='590EC74086'><tfoot id='590EC74086'></tfoot><noframes id='590EC74086'>

    • <optgroup id='590EC74086'><strike id='590EC74086'><sup id='590EC74086'></sup></strike><code id='590EC74086'></code></optgroup>
        1. <b id='590EC74086'><label id='590EC74086'><select id='590EC74086'><dt id='590EC74086'><span id='590EC74086'></span></dt></select></label></b><u id='590EC74086'></u>
          <i id='590EC74086'><strike id='590EC74086'><tt id='590EC74086'><pre id='590EC74086'></pre></tt></strike></i>

          focus

          focus

          author:leisure time    Page View:9
          Lessons Learned
          Molly Ferguson for STAT

          Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column. 

          Who we talked to:

          advertisement

          Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          Insitro, AI biotech unicorn, brings cash, new research to JPM 2024
          Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

          DaphneKoller,earlybiotechAIentrantInsitro'sfounder,CEOandboardmember.CourtesyJerrickMitra/InsitroNew

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

          MarkJ.Terrill/APAfollow-upstudyofafirst-of-its-kindcancertreatmentmayreflectsystemicbiases,theFoodan